Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01290263
Title Amgen 386 for Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90095 United States Details
Massachusetts General Hosptial Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
University of Massachusetts, Worcester Worcester Massachusetts 01655 United States Details
New York - Presbyterian/Columbia University Medical Center New York New York 10032 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field